MedPath

To study the effect of Chandrashoor ladu( dietary supplement) on minimising menstrual period related pain.

Not yet recruiting
Conditions
Primary dysmenorrhea,
Registration Number
CTRI/2020/05/025058
Lead Sponsor
CARC
Brief Summary

1. Primary dysmenorrhea is the commnest among menstruation related conditions. There are chances of increase in prevalence of primary dysmenorrhea in future due to consistently changing lifestyle.

2. Currently available treatment for dysmenorrhea includes use of NSAIDs, oral contraceptive medications, prostaglandin synthetase inhibitors ; if taken for longer periods may shoew potential side effects. While *Ayurvedic* treatments like *pichu, swedana, basti* etc. are not always feasible for patients.

3. Hence there is a need to find an easy solution. Adding certain food preparations in diet can improve the condition. Literature and previous study have proved effectiveness of *Chaturbeeja* (a set of four seeds) in relieving spasmodic pain.*Chandrashoor* ( *Lepidium sativum* Linn.) is one of content of *Chaturbeeja.*

4. Therefore this study will assess effect of *Chandrashoor ( Lepiduim sativum* Linn.*)* to relieve spasmodic pain of primary dysmenorrhea and minimize associated symptoms if added in diet in the form of ladu.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • 1.Patients with chief complaint of painful menses and associated symptoms at least for three cycles.
  • 2.Patients with pain for at least for first 2 days of the cycle.
  • 3.Nulliparous females.
  • 4.Age group-15 to 28 years irrespective of caste and religion.
Exclusion Criteria
  • 1.Patients with chronic illness for example, DM and any systemic disorder.
  • 2.Any diagnosed uterine pathology (Menorrhagia,Fibroid,Adenomycosis, Endometriosis).
  • 3.Patients undergoing hormonal treatment for Dysmenorrhea.
  • 4.Patients with Pitta Prakruti.
  • 5.Patients with heavy menstrual bleeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate role of chandrashoor Ladu in minimising spasmodic pain caused by kashtartava(primary dysmenorrhea).2 months
Secondary Outcome Measures
NameTimeMethod
To evaluate role of Chandrashoor Ladu in minimising Kashtartava(primary dysmenorrhea) associated symptoms.2 months

Trial Locations

Locations (1)

PDEA College of Ayurved and Research Centre.

🇮🇳

Pune, MAHARASHTRA, India

PDEA College of Ayurved and Research Centre.
🇮🇳Pune, MAHARASHTRA, India
Dr Supriya Dileep Sanap
Principal investigator
7709073146
supriyasanap5@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.